Navigation Links
22nd Century Group, Inc. CEO to Webcast, Live, at RetailInvestorConferences.com on December 5th
Date:12/2/2013

NEW YORK, Dec. 2, 2013 /PRNewswire/ -- 22nd Century Group, Inc. (OTCBB: XXII) today announced that Joseph Pandolfino, Chief Executive Officer, and Henry Sicignano III, President, will present at RetailInvestorConferences.com.

DATE:

December 5, 2013

TIME:   

1:15 PM EST

LINK:  

www.retailinvestorconferences.com click on the red "register / watch event now" button

This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in the presentation hall as well as the company's "virtual trade booth." If attendees are not able to join the event live on the day of the conference, an on-demand archive will be available for 90 days.

The Retail Investor Conferences event is part of the Virtual Investor Conference Series co-hosted by MUNCmedia, Better Investing (NAIC) and PR Newswire.  Individual investors, institutional investors, financial advisors and financial analysts are invited to attend.  

It is recommended that investors pre-register to save time and receive event updates.

About 22nd Century Group:

22nd Century Group, Inc. (OTCBB: XXII) is a plant biotechnology company whose proprietary technology allows for the levels of nicotine and other nicotinic alkaloids (e.g., nornicotine, anatabine and anabasine) in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. 22nd Century owns or is the exclusive licensee of 114 issued patents in 78 countries plus an additional 36 pending patent applications. Goodrich Tobacco Company, LLC and Hercules Pharmaceuticals, LLC are wholly-owned subsidiaries of 22nd Century. Goodrich Tobacco is focused on commercial tobacco products and potential modified risk cigarettes. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development. www.xxiicentury.com

About RetailInvestorConferences.com:

Since 2010, RetailInvestorConferences.com is the world's largest monthly virtual investor conference series that provides an interactive forum for presenting companies to meet directly with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites leading-edge online conferencing by PR Newswire with the investor communications capabilities of MUNCmedia's digital public relations, content marketing and audience development services and BetterInvesting's extensive retail investor audience network.


'/>"/>
SOURCE 22nd Century Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Grace Century, FZ LLC Publishes Annual Global and Regional Financial Predications for 2014
2. KaloBios to Present at BioCenturys NewsMakers in the Biotech Industry Conference
3. Ambit Announces Participation At The BioCentury NewsMakers in the Biotech Industry Conference
4. MEI Pharma to Present at BioCenturys NewsMakers in the Biotech Industry Conference
5. Quorum Review’s Mitchell Parrish Presents at Embracing Change: Clinical Research in the 21st Century
6. Dalia Dergham Joins Grace Century FZ LLC International Project Team
7. Grace Century Attends Provia Laboratories Cycle II Launch
8. Celladon Corporation To Present at BioCentury Future Leaders in the Biotech Industry Conference
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. GenoSpace Announces the Launch of a Cloud-Based "Information Ecosystem" for Advancing 21st-Century Personalized Medicine
11. Stanford scientists spark new interest in the century-old Edison battery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
Breaking Biology News(10 mins):